Daniel R. Goldstein

ORCID: 0000-0001-6695-979X · 2 papers in corpus
article 2011
No benefit from combining HE4 and CA125 as ovarian tumor markers in a clinical setting
Gynecologic Oncology ·doi:10.1016/j.ygyno.2011.02.022

ObjectiveAbout 70% of epithelial ovarian cancer patients (EOC) are diagnosed at advanced stage with a five-year survival rate of only 30%. Whilst CA125 detects peritoneally-spread disease, it has limited sensitivity for early cancers, many …

article 2003
Endometriosis simulating a colonic obstructive neoplasm
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology ·doi:10.1016/s0748-7983(03)00121-5